News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

A Randomized Phase II Study of Intrabucally Administered Electromagnetic Fields versus Placebo for Patients with Child-Pugh A or B Advanced Hepatocellular Carcinoma

Study Status:

Not yet active

Contact Information:

(956) 362-2394

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The primary goal of this study is to gather efficacy data concerning overall survival with electromagnetic fields when compared to a placebo amplitude-modulated radiofrequency electromagnetic field device in subjects who have failed or are intolerant to at least two previous systemic therapies.


Principal Investigator
Dr. Lee C. Drinkard
Edgar Lopez Pacheco
Wake Forest Baptist Comprehensive Cancer Center
Type of Trial
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram